A medical university in China is investigating the death of a girl who participated in a genetic editing trial. The trial was conducted by a prominent expert at a hospital affiliated with the university. This incident has raised serious concerns about ethics in China's biomedical industry.

The university has formed a task force to conduct a thorough investigation into the clinical trial and a related scientific article. The investigation was announced after two publications, Science and Retraction Watch, reported on the matter. Further details about the investigation and the trial are available from the source, including the involvement of the Faculty of Medicine at Shanghai Jiaotong University and the Hospital Xinhua.